Jacobs Levy Equity Management, Inc Palatin Technologies Inc Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $580,696 - $871,045	-1,209,785 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$0.68 - $1.25 $407,839 - $749,705	-599,764 Reduced 33.14%	1,209,785 $834,000
Q4 2020 Feb 16, 2021	BUY	$0.38 - $0.78 $264,644 - $543,216	696,432 Added 62.57%	1,809,549 $1.22 Million
Q3 2020 Nov 16, 2020	BUY	$0.47 - $0.64 $212,150 - $288,886	451,385 Added 68.21%	1,113,117 $526,000
Q2 2020 Aug 17, 2020	BUY	$0.41 - $0.73 $271,310 - $483,064	661,732 New	661,732 $339,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $17.5M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.